CF
RGNX icon

Corebridge Financial’s Regenxbio RGNX Stock Holding History

Corebridge Financial’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,786
Closed -$163K – 2188
2025
Q1 		$163K Sell
22,786
-103
-0.4% -$766 ﹤0.01% 2187
2024
Q4 		$177K Sell
22,889
-3,514
-13% -$33K ﹤0.01% 2249
2024
Q3 		$277K Sell
26,403
-271
-1% -$3.3K ﹤0.01% 2039
2024
Q2 		$312K Buy
+26,674
New +$415K ﹤0.01% 1941

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Corebridge Financial's RGNX Position: Q2 2025 in Review

Corebridge Financial sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 22,786 shares — an estimated $163K sold.

Corebridge Financial first reported a position in RGNX in Q2 2024 and held it in 4 quarters. The position peaked at $312K in Q2 2024. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

  • Corebridge Financial reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 22,786 Regenxbio shares in Q2 2025, an estimated $163K.
  • Corebridge Financial first reported a position in Regenxbio in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Regenxbio position peaked at $312K in Q2 2024.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.